Two major pathogenic MOG peptide epitopes (MOG40 54 and MOG44 54) have been used to construct peptide/H-2Db dimeric complexes to quantify the encephalitogenic CD8 T cell subsets [19].
Here, we have used a novel approach of microinjection of fluorescently labelled, highly purified, recombinant p110α/p85α complexes to quantify the degree of PM localization of wild-type and oncogenic mutant PI3Kα in cells maintained in growth media, and starved or stimulated cells.
Life, on the other hand, presents challenges far too complex to quantify or even define, much less solve.
They also include factors whose influence is more complex to quantify, such number and location of feeding points, diameter and length of inflow channels, angle of channel with respect to the main sprue axis.
These burden estimates result from a complex construct to quantify the comparative magnitude of health loss due to diseases, injuries and risk factors.
There could be other, less complex ways to quantify the amount of random error, not requiring a solid background in statistics for their proper interpretation.
A naïve thinking of identifying disease-related protein complex is to quantify the strength of associations between proteins and the query disease and then sum over the scores of member proteins to obtain a score for a protein complex.
We can use these optimized constraints to not only infer structural characteristics of the regulatory complex, but also to quantify the binding of these multi-meric complexes to different DNA sequences, and to accurately predict target genes.
This number (the p stands for probability) is arrived at through a complex calculation designed to quantify the probability that the results of an experiment were not due to chance.
The release rate of the peptide pyrene complex was calculated to quantify the transfer of pyrene into EPC vesicles.
